Bitter Pill: Merck’s PR Response To Vioxx Debacle Hard to Swallow

On Sept. 30 global drug maker Merck pulled its blockbuster arthritis drug Vioxx off the market after studies showed that using the drug could lead to increased risk of
heart attack and stroke. On November 5, more than a month later--amid a torrent of negative press--the front page of still consisted of a single document: The
original Sept. 30 press release announcing the Vioxx withdrawal, with additional links to PDF files containing doctor and patient information.